- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-NEDD4L
NEDD4L Polyclonal Antibody for WB, IHC, IF/ICC, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris et plus (1)
Applications
WB, IHC, IF/ICC, IP, CoIP, ELISA
Conjugaison
Non conjugué
N° de cat : 13690-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules C6, cellules HT-1080, cellules PC-12, cellules PC-3 | 
| Résultats positifs en IP | cellules C6, | 
| Résultats positifs en IHC | tissu de cancer de l'estomac humain,  tissu de cancer de la prostate humain il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. | 
| Résultats positifs en IF/ICC | cellules PC-3, | 
Dilution recommandée
| Application | Dilution | 
|---|---|
| Western Blot (WB) | WB : 1:1000-1:5000 | 
| Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate | 
| Immunohistochimie (IHC) | IHC : 1:500-1:2000 | 
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| KD/KO | See 6 publications below | 
| WB | See 42 publications below | 
| IHC | See 13 publications below | 
| IF | See 9 publications below | 
| IP | See 8 publications below | 
| CoIP | See 7 publications below | 
Informations sur le produit
13690-1-AP cible NEDD4L dans les applications de WB, IHC, IF/ICC, IP, CoIP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris | 
| Réactivité citée | rat, Humain, porc, souris | 
| Hôte / Isotype | Lapin / IgG | 
| Clonalité | Polyclonal | 
| Type | Anticorps | 
| Immunogène | NEDD4L Protéine recombinante Ag4565 | 
| Nom complet | neural precursor cell expressed, developmentally down-regulated 4-like | 
| Masse moléculaire calculée | 854 aa, 96 kDa | 
| Poids moléculaire observé | 112 kDa, 125 kDa | 
| Numéro d’acquisition GenBank | BC032597 | 
| Symbole du gène | NEDD4L | 
| Identification du gène (NCBI) | 23327 | 
| Conjugaison | Non conjugué | 
| Forme | Liquide | 
| Méthode de purification | Purification par affinité contre l'antigène | 
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol | 
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. | 
Informations générales
NEDD4L(E3 ubiquitin-protein ligase NEDD4-like) is also named as KIAA0439, NEDL3, Nedd4-2. It accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substratesand and is the principal ubiquitin ligase that selectively targets activated SMAD2 and SMAD3 for destruction (PMID:19917253). Nedd4L binds the PY motif of ENaC COOH terminals and catalyzes ubiquitination of the NH2 terminus of the protein for subsequent degradation (PMID:18268134). It has some isoforms produced by alternative splicing. This antibody may have cross reaction with NEDD4 due to the high homology of the antigen.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for NEDD4L antibody 13690-1-AP | Download protocol | 
| IHC protocol for NEDD4L antibody 13690-1-AP | Download protocol | 
| IF protocol for NEDD4L antibody 13690-1-AP | Download protocol | 
| IP protocol for NEDD4L antibody 13690-1-AP | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
Publications
| Species | Application | Title | 
|---|---|---|
| Nat Genet Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia. | ||
| Cell Death Differ Aagab acts as a novel regulator of NEDD4-1-mediated Pten nuclear translocation to promote neurological recovery following hypoxic-ischemic brain damage. | ||
| Theranostics JP1 suppresses proliferation and metastasis of melanoma through MEK1/2 mediated NEDD4L-SP1-Integrin αvβ3 signaling. | ||
| Pharmacol Res Piezo2 channel in nodose ganglia neurons is essential in controlling hypertension in a pathway regulated directly by Nedd4-2. | ||
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
| FH Andrew (Verified Customer) (07-23-2025) | This antibody worked as advertised with little to no non-specific staining 
 | 












